Advanced Stage Head and Neck Cancer (DBCOND0039453)

Identifiers

Synonyms

Not Available

Associated Data

Indicated Drugs and Targets

Drug	Description	Targets
Nimotuzumab	An EGFR-targeting monoclonal antibody used in the treatment of squamous cell carcinomas of the head and neck and glioblastomas.	No drug targets

Clinical Trials

Identifier	Title	Drug(s)	Purpose	Phase	Status
NCT00578032	Reconstructive Surgery For Head And Neck Cancer Patients	No drug interventions	Not Available	Not Available	completed